node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
A1BG | AHSG | ENSBTAP00000069446 | ENSBTAP00000000673 | Alpha-1B-glycoprotein. | Alpha-2-HS-glycoprotein; Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Suggested to have lymphocyte stimulating properties, lipid binding capability and to bind thyroid hormone. | 0.819 |
A1BG | APOH | ENSBTAP00000069446 | ENSBTAP00000002492 | Alpha-1B-glycoprotein. | Beta-2-glycoprotein 1; Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. | 0.673 |
A1BG | ITIH1 | ENSBTAP00000069446 | ENSBTAP00000010318 | Alpha-1B-glycoprotein. | Inter-alpha-trypsin inhibitor heavy chain H1; May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan which are essential to cells undergoing biological processes. | 0.551 |
A1BG | ITIH2 | ENSBTAP00000069446 | ENSBTAP00000018701 | Alpha-1B-glycoprotein. | Inter-alpha-trypsin inhibitor heavy chain H2. | 0.624 |
A1BG | SERPINA1 | ENSBTAP00000069446 | ENSBTAP00000065816 | Alpha-1B-glycoprotein. | Alpha-1-antiproteinase; Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Inhibits trypsin, chymotrypsin and plasminogen activator (By similarity); Belongs to the serpin family. | 0.569 |
A1BG | SERPINC1 | ENSBTAP00000069446 | ENSBTAP00000072452 | Alpha-1B-glycoprotein. | Antithrombin-III; Most important serine protease inhibitor in plasma that regulates the blood coagulation cascade. AT-III inhibits thrombin, matriptase-3/TMPRSS7, as well as factors IXa, Xa and XIa. Its inhibitory activity is greatly enhanced in the presence of heparin (By similarity). | 0.703 |
AHSG | A1BG | ENSBTAP00000000673 | ENSBTAP00000069446 | Alpha-2-HS-glycoprotein; Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Suggested to have lymphocyte stimulating properties, lipid binding capability and to bind thyroid hormone. | Alpha-1B-glycoprotein. | 0.819 |
AHSG | APOH | ENSBTAP00000000673 | ENSBTAP00000002492 | Alpha-2-HS-glycoprotein; Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Suggested to have lymphocyte stimulating properties, lipid binding capability and to bind thyroid hormone. | Beta-2-glycoprotein 1; Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. | 0.956 |
AHSG | C8A | ENSBTAP00000000673 | ENSBTAP00000004913 | Alpha-2-HS-glycoprotein; Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Suggested to have lymphocyte stimulating properties, lipid binding capability and to bind thyroid hormone. | Complement C8 alpha chain. | 0.449 |
AHSG | ITIH1 | ENSBTAP00000000673 | ENSBTAP00000010318 | Alpha-2-HS-glycoprotein; Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Suggested to have lymphocyte stimulating properties, lipid binding capability and to bind thyroid hormone. | Inter-alpha-trypsin inhibitor heavy chain H1; May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan which are essential to cells undergoing biological processes. | 0.562 |
AHSG | ITIH2 | ENSBTAP00000000673 | ENSBTAP00000018701 | Alpha-2-HS-glycoprotein; Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Suggested to have lymphocyte stimulating properties, lipid binding capability and to bind thyroid hormone. | Inter-alpha-trypsin inhibitor heavy chain H2. | 0.837 |
AHSG | SERPINA1 | ENSBTAP00000000673 | ENSBTAP00000065816 | Alpha-2-HS-glycoprotein; Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Suggested to have lymphocyte stimulating properties, lipid binding capability and to bind thyroid hormone. | Alpha-1-antiproteinase; Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Inhibits trypsin, chymotrypsin and plasminogen activator (By similarity); Belongs to the serpin family. | 0.921 |
AHSG | SERPINA10 | ENSBTAP00000000673 | ENSBTAP00000013050 | Alpha-2-HS-glycoprotein; Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Suggested to have lymphocyte stimulating properties, lipid binding capability and to bind thyroid hormone. | Serpin family A member 10; Belongs to the serpin family. | 0.570 |
AHSG | SERPINC1 | ENSBTAP00000000673 | ENSBTAP00000072452 | Alpha-2-HS-glycoprotein; Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Suggested to have lymphocyte stimulating properties, lipid binding capability and to bind thyroid hormone. | Antithrombin-III; Most important serine protease inhibitor in plasma that regulates the blood coagulation cascade. AT-III inhibits thrombin, matriptase-3/TMPRSS7, as well as factors IXa, Xa and XIa. Its inhibitory activity is greatly enhanced in the presence of heparin (By similarity). | 0.897 |
AHSG | SERPINF2 | ENSBTAP00000000673 | ENSBTAP00000027793 | Alpha-2-HS-glycoprotein; Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Suggested to have lymphocyte stimulating properties, lipid binding capability and to bind thyroid hormone. | Alpha-2-antiplasmin; Serine protease inhibitor. The major targets of this inhibitor are plasmin and trypsin, but it also inactivates matriptase- 3/TMPRSS7 and chymotrypsin (By similarity). | 0.805 |
APOH | A1BG | ENSBTAP00000002492 | ENSBTAP00000069446 | Beta-2-glycoprotein 1; Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. | Alpha-1B-glycoprotein. | 0.673 |
APOH | AHSG | ENSBTAP00000002492 | ENSBTAP00000000673 | Beta-2-glycoprotein 1; Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. | Alpha-2-HS-glycoprotein; Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Suggested to have lymphocyte stimulating properties, lipid binding capability and to bind thyroid hormone. | 0.956 |
APOH | C8A | ENSBTAP00000002492 | ENSBTAP00000004913 | Beta-2-glycoprotein 1; Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. | Complement C8 alpha chain. | 0.428 |
APOH | ITIH1 | ENSBTAP00000002492 | ENSBTAP00000010318 | Beta-2-glycoprotein 1; Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. | Inter-alpha-trypsin inhibitor heavy chain H1; May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan which are essential to cells undergoing biological processes. | 0.673 |
APOH | ITIH2 | ENSBTAP00000002492 | ENSBTAP00000018701 | Beta-2-glycoprotein 1; Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. | Inter-alpha-trypsin inhibitor heavy chain H2. | 0.806 |